This week marks an exciting milestone for Alto Pharmacy as they have officially joined Fuze Health, a new force in technology-enabled healthcare born from the merger of Truepill and LetsGetChecked. This union represents a bold step toward reshaping how patients access and experience care.

At Samudra Pacific, our mission has always been to back visionary founders that are redefining outdated systems. When we first met Alto’s team, the pharmacy experience was ripe for reinvention. Long lines, missed medications, and impersonal service were too often the norm. Alto’s team envisioned something radically different: a patient-first, tech-powered pharmacy that met people where they are.

The acquisition by Fuze Health is more than a strategic alignment; it’s a shared vision in action. Fuze is building a healthcare ecosystem that bridges diagnostics, virtual care, and medication management that integrates seamlessly into the home. Alto brings unmatched pharmacy capabilities to this mix. Capabilities that are essential to delivering timely, personalized treatment at scale.

For us as investors, it’s been an honor to witness Alto’s journey from a small, determined team in San Francisco to a national leader in digital pharmacy. Their success is a testament to what’s possible when healthcare innovation stays grounded in empathy, and when great teams are given the space to build for the long term.

Congratulations to Alicia Boler Davis, Jamie Karraker, Matt Gamache-Asselin Jamie Cohen, Dave Graybeal and the entire Alto team and welcome to this new chapter with Fuze Health. We couldn’t be prouder of the impact you’ve made, and the future you’re helping to create.